Yoest, J. (2017). Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: A short review. ImmunoTargets and therapy, 6, 73-82. https://doi.org/10.2147/ITT.S126227
Chicago Style (17th ed.) CitationYoest, Jennifer. "Clinical Features, Predictive Correlates, and Pathophysiology of Immune-related Adverse Events in Immune Checkpoint Inhibitor Treatments in Cancer: A Short Review." ImmunoTargets and Therapy 6 (2017): 73-82. https://doi.org/10.2147/ITT.S126227.
MLA (9th ed.) CitationYoest, Jennifer. "Clinical Features, Predictive Correlates, and Pathophysiology of Immune-related Adverse Events in Immune Checkpoint Inhibitor Treatments in Cancer: A Short Review." ImmunoTargets and Therapy, vol. 6, 2017, pp. 73-82, https://doi.org/10.2147/ITT.S126227.